US Contrast Media Market

The US contrast media market is expected to reach USD 4.06 billion by 2031, from USD 2.97 billion in 2026, with a CAGR of 6.5%. In the US, the use of contrast media in radiology is driven by the growing adoption of advanced imaging and intervention technologies across hospitals, ambulatory surgical centers, and outpatient radiology clinics. The rise of imaging-guided procedures in cardiology, oncology, and trauma care has further boosted the demand for contrast-enhanced images. The expansion of outpatient diagnostic imaging services, along with improvements in high-efficiency imaging systems and automated image-processing technologies, also reinforces the demand and routine application of contrast media.

Key market players include GE Healthcare (US), Bayer AG (Germany), Bracco Imaging (Italy), and Guerbet (France), among others. These companies employ various organic and inorganic strategies to maintain a strong foothold in the US contrast media market.

To know about the assumptions considered for the study download the pdf brochure

GE Healthcare is a leading company in the US contrast media market. It offers a wide range of iodinated contrast media products through its Pharmaceutical Diagnostics division. The company also provides MRI contrast media products. These products are widely used in US healthcare institutions for imaging procedures, such as computed tomography scans, magnetic resonance imaging scans, and X-ray scans. GE has the ability to deliver integrated solutions comprising both contrast media products and imaging equipment. This has resulted in high efficiency and improved patient safety in the operations of healthcare organizations.

Bayer AG is a major provider of contrast media such as gadolinium and iodine compounds, which are used as contrast agents in MRI and CT scan procedures like brain scans, liver scans, and angiographies. The company has three key operating segments: Pharmaceuticals, Consumer Health, and Crop Science; contrast media are part of the Pharmaceuticals segment. In addition to contrast agents, Bayer supplies injection equipment and software solutions for analytical purposes. Its excellent patient safety program, ability to optimize portfolios, and commitment to high-volume imaging help the company maintain a strong foothold in the US.

Market Ranking:

In the US contrast media market, a few major players generate most sales, resulting in high market concentration. Key participants such as GE Healthcare, Bayer AG, Bracco Imaging, and Guerbet offer a wide range of contrast media products, have established country-wide distribution networks, and maintain strong ties with US healthcare facilities, which help them hold a large market share. Other players like Nano Therapeutics Pvt, Trivitron Healthcare, and BioPAL, Inc. record lower sales due to their focus on specific areas such as iodinated contrast media, gadolinium-based contrast media, and ultrasound contrast media, as well as computed tomography, magnetic resonance imaging, and interventional imaging applications. Factors like the high volume of imaging procedures, the need for contrast media in oncology and cardiovascular diagnostics, and innovations aimed at improving image quality, workflow efficiency, and patient safety all drive growth in this industry.

Related Reports:

US Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound, X-ray), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology), Route of Administration (IV, Oral, Rectal), End User-Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]